This is HDAX
We are dedicated to bringing transformative therapies to patients – empowering them to embrace life to its fullest.

Our Story

Born out of the lab of Professor Patrick Gunning at the University of Toronto, a serial entrepreneur with a successful track record, HDAX Therapeutics was created with a foundation in translational science and a mission to advance revolutionary treatments.
Our entrepreneurial drug developers have built the technology behind HDAX from a mere concept into distinct programs with therapeutical potential in neurology, cardiometabolic diseases and more. HDAX is well-charged with an extensive network, profound passion and unwavering tenacity to transform therapeutic outcomes for patients.

Our Mission

HDAX exists to deliver meaningful medicines for patients. We recognize the challenges with current HDAC6 targeting strategies, and are fundamentally reconceptualizing the way it is approached to unlock its full therapeutic potential and revolutionize patient outcomes. Our values serve as our inspiration to excel in our endeavours and never lose sight of why our work matters – to change patients’ lives.
Artboard 15 copy 3 1
Artboard 15 copy 3 1

Innovation

Artboard 15 copy 4 1
Artboard 15 copy 4 1

Collaboration

Artboard 15 copy 5 2
Artboard 15 copy 5 2

Integrity

Our Team

HDAX has a unique blend of experienced leaders and passionate founders equipped with scientific background and business expertise to lead the future of precision HDAC6 targeting for diseases with high unmet needs.

Leadership

Nabanita Nawar, PhD

CEO & Co-founder

Pimyupa Manaswiyoungkul, PhD

COO & Co-founder

Bertrand Le Bourdonnec, PhD

CSO

Board of Directors

Roman Fleck, PhD

Director

Neal Muni, M.D., MSPH

Director

Brock Reeve

Director

Prakash Gowd, MBA

Director

Advisors

Professor Patrick Gunning, PhD

Co-Founder

Professor Ahmet Hoke, PhD

Scientific and Clinical

Board of Directors

No data was found

Our Partners

HDAX has partnered with renowned investors, accelerators, and institutions who share our vision of a better treatment paradigm.
Berkley Skydeck 1
Facit 1
Mitacs 1
Ontario Bioscience 1
TIAP 1
University of Toronto 1
OCI Logo White v5
EOS Logo v3
seedfolio white v1
VitaDAO 1
Berkley Skydeck 1
Facit 1
Mitacs 1
Ontario Bioscience 1
TIAP 1
University of Toronto 1
VitaDAO 1